- Home
- ICCC vs IZM Comparison
ICCC vs IZM Comparison
Compare ICCC & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCC
- IZM
- Stock Information
- Founded
- ICCC 1982
- IZM 2011
- Country
- ICCC United States
- IZM China
- Employees
- ICCC N/A
- IZM N/A
- Industry
- ICCC Biotechnology: Pharmaceutical Preparations
- IZM Consumer Electronics/Video Chains
- Sector
- ICCC Health Care
- IZM Consumer Discretionary
- Exchange
- ICCC Nasdaq
- IZM Nasdaq
- Market Cap
- ICCC 28.0M
- IZM 24.9M
- IPO Year
- ICCC 1987
- IZM 2023
- Fundamental
- Price
- ICCC $4.71
- IZM $2.02
- Analyst Decision
- ICCC
- IZM
- Analyst Count
- ICCC 0
- IZM 0
- Target Price
- ICCC N/A
- IZM N/A
- AVG Volume (30 Days)
- ICCC 22.4K
- IZM 37.3K
- Earning Date
- ICCC 11-13-2024
- IZM 12-31-2024
- Dividend Yield
- ICCC N/A
- IZM N/A
- EPS Growth
- ICCC N/A
- IZM N/A
- EPS
- ICCC N/A
- IZM N/A
- Revenue
- ICCC $23,838,001.00
- IZM $177,933,890.00
- Revenue This Year
- ICCC N/A
- IZM N/A
- Revenue Next Year
- ICCC N/A
- IZM N/A
- P/E Ratio
- ICCC N/A
- IZM N/A
- Revenue Growth
- ICCC 46.37
- IZM N/A
- 52 Week Low
- ICCC $3.34
- IZM $1.86
- 52 Week High
- ICCC $5.82
- IZM $52.21
- Technical
- Relative Strength Index (RSI)
- ICCC 56.95
- IZM 37.44
- Support Level
- ICCC $4.38
- IZM $1.98
- Resistance Level
- ICCC $5.23
- IZM $2.19
- Average True Range (ATR)
- ICCC 0.47
- IZM 0.10
- MACD
- ICCC -0.04
- IZM -0.02
- Stochastic Oscillator
- ICCC 22.92
- IZM 13.33
About ICCC ImmuCell Corporation
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.